These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 26580149)
21. Phase II study of oxaliplatin for treatment of patients with mucosa-associated lymphoid tissue lymphoma. Raderer M; Wöhrer S; Bartsch R; Prager G; Drach J; Hejna M; Gaiger A; Turetschek K; Jaeger U; Streubel B; Zielinski CC J Clin Oncol; 2005 Nov; 23(33):8442-6. PubMed ID: 16293875 [TBL] [Abstract][Full Text] [Related]
22. Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with mitoxantrone, chlorambucil and prednisone (MCP). Wöhrer S; Drach J; Hejna M; Scheithauer W; Dirisamer A; Püspök A; Chott A; Raderer M Ann Oncol; 2003 Dec; 14(12):1758-61. PubMed ID: 14630681 [TBL] [Abstract][Full Text] [Related]
23. Primary radiation therapy in patients with localized orbital marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT Lymphoma). Son SH; Choi BO; Kim GW; Yang SW; Hong YS; Choi IB; Kim YS Int J Radiat Oncol Biol Phys; 2010 May; 77(1):86-91. PubMed ID: 19632068 [TBL] [Abstract][Full Text] [Related]
24. Retrospective comparison of the effectiveness of various treatment modalities of extragastric MALT lymphoma: a single-center analysis. Wöhrer S; Kiesewetter B; Fischbach J; Müllauer L; Troch M; Lukas J; Mayerhoefer ME; Raderer M Ann Hematol; 2014 Aug; 93(8):1287-95. PubMed ID: 24633660 [TBL] [Abstract][Full Text] [Related]
25. Lacrimal gland extranodal marginal zone B-cell lymphoma of MALT-type. Kao SC; Kau HC; Tsai CC; Tsay SH; Yang CF; Wu JS; Hsu WM Am J Ophthalmol; 2007 Feb; 143(2):311-316. PubMed ID: 17184716 [TBL] [Abstract][Full Text] [Related]
26. Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-Hodgkin's lymphoma. Kong LR; Huang CF; Hakimian D; Variakojis D; Klein L; Kuzel TM; Gordon LI; Zanzig C; Wollins E; Tallman MS Cancer; 1998 Mar; 82(5):957-64. PubMed ID: 9486587 [TBL] [Abstract][Full Text] [Related]
27. Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group. Conconi A; Raderer M; Franceschetti S; Devizzi L; Ferreri AJ; Magagnoli M; Arcaini L; Zinzani PL; Martinelli G; Vitolo U; Kiesewetter B; Porro E; Stathis A; Gaidano G; Cavalli F; Zucca E Br J Haematol; 2014 Jul; 166(1):69-76. PubMed ID: 24673512 [TBL] [Abstract][Full Text] [Related]
28. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. Tsang RW; Gospodarowicz MK; Pintilie M; Wells W; Hodgson DC; Sun A; Crump M; Patterson BJ J Clin Oncol; 2003 Nov; 21(22):4157-64. PubMed ID: 14615444 [TBL] [Abstract][Full Text] [Related]
29. Long-term treatment of localized gastric marginal zone B-cell mucosa associated lymphoid tissue lymphoma including incidence of metachronous gastric cancer. Ono S; Kato M; Takagi K; Kodaira J; Kubota K; Matsuno Y; Komatsu Y; Asaka M J Gastroenterol Hepatol; 2010 Apr; 25(4):804-9. PubMed ID: 20492338 [TBL] [Abstract][Full Text] [Related]
30. Treatment of indolent non-Hodgkin's lymphoma with cladribine as single-agent therapy and in combination with mitoxantrone. Armitage JO; Tobinai K; Hoelzer D; Rummel MJ Int J Hematol; 2004 May; 79(4):311-21. PubMed ID: 15218957 [TBL] [Abstract][Full Text] [Related]
31. Activity of rituximab plus cyclophosphamide, doxorubicin/mitoxantrone, vincristine and prednisone in patients with relapsed MALT lymphoma. Raderer M; Wohrer S; Streubel B; Drach J; Jager U; Turetschek K; Troch M; Puspok A; Zielinski CC; Chott A Oncology; 2006; 70(6):411-7. PubMed ID: 17220639 [TBL] [Abstract][Full Text] [Related]
32. Non-gastric advanced mucosa-associated lymphoid tissue (MALT) lymphoma has worse prognosis than gastric MALT lymphoma even when treated with rituximab-containing chemotherapy. Ueda K; Terui Y; Yokoyama M; Sakajiri S; Nishimura N; Tsuyama N; Takeuchi K; Hatake K Leuk Lymphoma; 2013 Sep; 54(9):1928-33. PubMed ID: 23216271 [TBL] [Abstract][Full Text] [Related]
33. Oral chlorambucil for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue of the orbit. Ben Simon GJ; Cheung N; McKelvie P; Fox R; McNab AA Ophthalmology; 2006 Jul; 113(7):1209-13. PubMed ID: 16647129 [TBL] [Abstract][Full Text] [Related]
34. Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue of the Salivary Glands: A Multicenter, International Experience of 248 Patients (IELSG 41). Jackson AE; Mian M; Kalpadakis C; Pangalis GA; Stathis A; Porro E; Conconi A; Cortelazzo S; Gaidano G; Lopez Guillermo A; Johnson PW; Martelli M; Martinelli G; Thieblemont C; McPhail ED; Copie-Bergman C; Pileri SA; Jack A; Campo E; Mazzucchelli L; Ristow K; Habermann TM; Cavalli F; Nowakowski GS; Zucca E Oncologist; 2015 Oct; 20(10):1149-53. PubMed ID: 26268740 [TBL] [Abstract][Full Text] [Related]
35. Rituximab combined with cladribine or with cladribine and cyclophosphamide in heavily pretreated patients with indolent lymphoproliferative disorders and mantle cell lymphoma. Robak T; Smolewski P; Cebula B; Szmigielska-Kaplon A; Chojnowski K; Blonski JZ Cancer; 2006 Oct; 107(7):1542-50. PubMed ID: 16948126 [TBL] [Abstract][Full Text] [Related]
39. Treatment of localized oral MALT lymphoma by rituximab: a case report. Yamagata K; Onizawa K; Kojima H; Yoshida H Oral Maxillofac Surg; 2008 Dec; 12(4):227-30. PubMed ID: 18830723 [TBL] [Abstract][Full Text] [Related]
40. A phase II study of lenalidomide in patients with extranodal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT lymphoma). Kiesewetter B; Troch M; Dolak W; Müllauer L; Lukas J; Zielinski CC; Raderer M Haematologica; 2013 Mar; 98(3):353-6. PubMed ID: 22899582 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]